Cognition Therapeutics (CGTX) Stock: Buy, Sell, or Hold?
CGTX - Cognition Therapeutics, Inc. Common Stock
$0.93
0.03 (3.80%)
▲
5d:
-1.22%
30d:
-11.9%
90d:
-13.54%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When CGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CGTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CGTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CGTX is currently trading at $0.93, which is considered oversold relative to its 30-day fair value range of $0.95 to $1.04.
Technical Outlook: Technically, CGTX is in a strong uptrend. Immediate support is located at $0.89, while resistance sits at $1.07. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.33 (+260.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CGTX is in a strong uptrend. Immediate support is located at $0.89, while resistance sits at $1.07. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.33 (+260.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.95 -
$1.04
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 260.3% below Wall St target ($3.33)
- NEUTRAL: Bottoming setup forming (54/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$0.95 -
$1.04
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.89
Resistance Level
$1.08
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.21
Wall Street Target
$3.33
(+260.3%)
Share & Embed Analysis
Last updated: October 03, 2026 1:39 PM ET
Data refreshes hourly during market hours. Next update: 2:39 PM
Data refreshes hourly during market hours. Next update: 2:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGTX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John Brendan Doyle
BUY
10000 shares
2026-04-16
Lisa Ricciardi
BUY
9175 shares
2026-04-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
